Patent · US Active

Pyrazinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes

US8637522B2 · kind B2 · utility

0Cited by

2References

23Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Gerard Botton · Buc, FR
Micheline Kergoat · Les Ulis, FR
Christine Charon · Gometz-le-Châtel, FR
Samer Elbawab · Les Ulis, FR

Key dates

Filing date	Jan 15, 2009
Grant date	Jan 28, 2014
Priority date	—
Expiry date	Aug 5, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D241/18
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to pyrazinone derivatives of formula (I), wherein n, R1, R2, R3 and R4 are as defined in claim 1, as insulin secretion stimulators. The invention also relates to the preparation and use of these pyrazinone derivatives for the prophylaxis and/or treatment of diabetes and pathologies associated.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.